LOVAZA for Cardiovascular disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where LOVAZA was used for Cardiovascular disorder.
Most Reported Side Effects for LOVAZA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product quality issue | 48 | 15.8% | 0 | 1 |
| Eructation | 26 | 8.6% | 0 | 0 |
| Dysgeusia | 24 | 7.9% | 0 | 0 |
| Off label use | 21 | 6.9% | 0 | 1 |
| Drug ineffective | 15 | 5.0% | 0 | 0 |
| Diarrhoea | 14 | 4.6% | 0 | 0 |
| Nausea | 14 | 4.6% | 0 | 0 |
| Abdominal discomfort | 13 | 4.3% | 0 | 0 |
| Medication residue present | 13 | 4.3% | 0 | 0 |
| Therapeutic response unexpected | 13 | 4.3% | 0 | 0 |
| Flatulence | 12 | 4.0% | 0 | 0 |
| Dyspepsia | 10 | 3.3% | 0 | 0 |
| Blood triglycerides increased | 9 | 3.0% | 0 | 0 |
| Abdominal pain upper | 8 | 2.6% | 0 | 0 |
| Alanine aminotransferase increased | 8 | 2.6% | 0 | 0 |
Other Indications for LOVAZA
Blood triglycerides increased (106)
Product used for unknown indication (96)
Blood cholesterol increased (23)
Blood cholesterol (9)
Cardiac disorder (7)
Blood triglycerides (6)
Other Drugs Used for Cardiovascular disorder
EVOLOCUMAB (669)
ASPIRIN (304)
ATORVASTATIN (172)
CLOPIDOGREL BISULFATE (121)
TICAGRELOR (110)
METOPROLOL (104)
BOCOCIZUMAB (103)
INVESTIGATIONAL PRODUCT (83)
SEMAGLUTIDE (78)
FUROSEMIDE (76)